Literature DB >> 30293663

Clinical impact of advanced chronic kidney disease on outcomes and in-hospital complications of Takotsubo Syndrome (broken-heart-syndrome): Propensity-matched national study.

Ahmed S Yassin1, Oluwole Adegbala2, Ahmed Subahi3, Hossam Abubakar3, Emmanuel Akintoye3, Mohamed Abdelrahamn4, Abdelrahman Ahmed3, Anika Agarwal3, Mohamed Shokr5, Mohit Pahuja5, Mahir Elder5, Amir Kaki5, Theodore Schreiber5, Tamam Mohamad5.   

Abstract

Multiple studies evaluated the outcomes and complications rate of Takotsubo Syndrome (TTS) in patients with and without advanced chronic kidney disease (CKD), revealed conflicting results. This study aims to assess the clinical outcomes and impact of advanced CKD on patients hospitalized with Takotsubo Syndrome. Patients who presented with Takotsubo cardiomyopathy between 2010 and 2014 were identified in the National Inpatient Sample (NIS) database using the International Classification of Diseases, 9th Revision, Clinical Modification (ICD-9-CM), and subsequently were divided into two groups, with advanced CKD and without advanced CKD. NIS is the largest all-payer inpatient stays database in the United States. The primary outcome was the effect of advanced CKD on inpatient mortality in comparison to the non-advanced CKD group. Secondary outcomes were the impact of CKD on TTS in-hospital complications. We also evaluated the length of hospital stay and the cost of hospitalization. Propensity score-matched analysis was performed to address potential confounding. The advanced CKD group had no significant increase in the risk of In-hospital mortality (OR 0.99; 95% CI 0.75-1.31, P = 0.269). However, advanced CKD patients were more likely to develop acute kidney injury (AKI) requiring dialysis (OR: 5.12, 95% CI: 3.16-8.30, P = <0.0001), and were more likely to stay longer at the hospital (OR 1.12; 95% CI 1.03 to 1.22, P 0.010). In conclusion, advanced chronic kidney disease does not increase immediate in-hospital mortality, neither most of the TTS in-hospital complications, apart from AKI and hospital length of stay, in comparison to the patients with non-advanced CKD.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Chronic kidney disease; Cost of treatment; Length of stay; Mortality; NIS database; Outcomes; Takotsubo Syndrome

Mesh:

Year:  2018        PMID: 30293663     DOI: 10.1016/j.ijcard.2018.09.098

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  6 in total

1.  Glomerular Filtration Rate as a Predictor of Outcome in Acute Coronary Syndrome Complicated by Atrial Fibrillation.

Authors:  Domenico Santoro; Guido Gembillo; Giuseppe Andò
Journal:  J Clin Med       Date:  2020-05-14       Impact factor: 4.241

2.  Takotsubo Syndrome in the Dialysis Patient - Challenging Diagnosis in a Unique Population.

Authors:  Charlotte Perrett; Debasish Banerjee
Journal:  Indian J Nephrol       Date:  2019 Nov-Dec

3.  The Impact of COPD on in-Hospital Outcomes in Patients with Takotsubo Cardiomyopathy.

Authors:  Pengyang Li; Xiaojia Lu; Catherine Teng; Peng Cai; Mark Kranis; Qiying Dai; Bin Wang
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2020-09-29

4.  The Association Between Hyperlipidemia and In-Hospital Outcomes in Takotsubo Cardiomyopathy.

Authors:  Pengyang Li; Xiaojia Lu; Catherine Teng; Michelle Hadley; Peng Cai; Qiying Dai; Bin Wang
Journal:  Diabetes Metab Syndr Obes       Date:  2021-01-12       Impact factor: 3.168

5.  Racial differences in takotsubo cardiomyopathy outcomes in a large nationwide sample.

Authors:  Raja Zaghlol; Amit K Dey; Sameer Desale; Ana Barac
Journal:  ESC Heart Fail       Date:  2020-03-09

6.  Takotsubo Syndrome during Haemodialysis.

Authors:  Nikolaos Tsigaridas; Stavros Mantzoukis; Marina Gerasimou; Konstantinos Bakas; Emilios Andrikos; Elisavet Kokkolou; Aphrodite Tsinta; Dimitrios Patsouras
Journal:  Indian J Nephrol       Date:  2019 Nov-Dec
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.